Compare GH & KD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GH | KD |
|---|---|---|
| Founded | 2011 | 2020 |
| Country | United States | United States |
| Employees | N/A | 80000 |
| Industry | Medical Specialities | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 22.9B | 2.8B |
| IPO Year | 2018 | 2021 |
| Metric | GH | KD |
|---|---|---|
| Price | $162.78 | $13.01 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 19 | 7 |
| Target Price | ★ $119.79 | $25.92 |
| AVG Volume (30 Days) | 1.7M | ★ 3.5M |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 6.74 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $982,021,000.00 | ★ $15,092,000,000.00 |
| Revenue This Year | $33.30 | $3.73 |
| Revenue Next Year | $28.27 | $0.08 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 32.88 | 0.23 |
| 52 Week Low | $53.40 | $10.10 |
| 52 Week High | $176.58 | $32.97 |
| Indicator | GH | KD |
|---|---|---|
| Relative Strength Index (RSI) | 51.63 | 49.02 |
| Support Level | $153.82 | $12.10 |
| Resistance Level | $173.94 | $13.77 |
| Average True Range (ATR) | 7.92 | 0.52 |
| MACD | -0.89 | -0.03 |
| Stochastic Oscillator | 45.68 | 47.06 |
Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company's main franchises are Guardant360 for genomic profiling of tumors, Reveal for molecular residual disease testing, and Shield for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
Kyndryl Holdings Inc is a technology services and infrastructure services provider company. It provides advisory, implementation, and managed services across a range of technology domains to help customers manage and modernize enterprise IT environments in support of their business and transformation objectives. The company's reportable segments consist of the following: Principal Markets which represents its operations in operations in, Canada, France, Germany, India, Italy, Spain, Portugal, and the United Kingdom / Ireland, United States, Japan, and Strategic Markets. It derives maximum revenue from the United States.